92848-18-5 Usage
Chemical structure
A pyrrolidine derivative containing a pyrrolidine group, an ethyl group, and a nitro-phenoxy group.
Application
Used in medicinal chemistry and pharmaceutical research as a building block for the synthesis of various bioactive molecules.
Versatility
Its unique structure and functional groups make it a versatile intermediate for the preparation of diverse organic compounds.
Potential applications
Has potential applications in drug discovery and development.
Nitro-phenoxy group
The nitro-phenoxy group in 1-[2-(3-nitro-phenoxy)-ethyl]-pyrrolidine may confer specific chemical properties that can be utilized in various synthetic transformations and chemical reactions.
Implications
It is a valuable chemical building block with potential implications in the development of novel pharmaceuticals and biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 92848-18-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,8,4 and 8 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 92848-18:
(7*9)+(6*2)+(5*8)+(4*4)+(3*8)+(2*1)+(1*8)=165
165 % 10 = 5
So 92848-18-5 is a valid CAS Registry Number.
92848-18-5Relevant academic research and scientific papers
IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION
-
, (2011/05/11)
Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).
Metasubstituted thiazolidinones, their manufacture and use as a drug
-
Page/Page column 41, (2010/11/25)
This invention involves thiazolidinone of general formula (I) and its creation and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.
Novel substituted diamine derivatives useful as motilin antagonists
-
, (2008/06/13)
The present invention relates to novel substituted diamine derivatives for the formula wherein R1, R2, R3, R4, X1, X2, X3, X4, A, Y and n are as described in the speci
